A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
A Finnish punk band whose members have autism and Down's Syndrome have been chosen as the country's entry for the Eurovision Song Contest.
The PM promises to double to 200,000 the number of homes built under an existing scheme aimed at easing Britain's housing shortage.
The Met Office has weather warnings in place for snow and ice until 10am in the north and west.